Published in Neurologist on July 01, 2007
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet (2009) 14.86
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet (2011) 9.23
Lithium delays progression of amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A (2008) 5.37
Diffusion-tensor MR imaging of corticospinal tract in amyotrophic lateral sclerosis and progressive muscular atrophy. Radiology (2005) 1.90
Mutations of FUS gene in sporadic amyotrophic lateral sclerosis. J Med Genet (2009) 1.79
Disulfiram neuropathy: two cases of distal axonopathy. Clin Toxicol (Phila) (2008) 1.47
Ramsay-Hunt syndrome complicated by unilateral multiple cranial nerve palsies. Neurol Sci (2008) 1.44
Intracranial hypotension syndrome following chiropractic manipulation of the cervical spine. J Headache Pain (2006) 1.43
Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer's disease. Neurobiol Aging (2002) 1.35
Early-onset familial parkinsonism due to POLG mutations. Ann Neurol (2006) 1.31
Clinical and genetic heterogeneity in progressive external ophthalmoplegia due to mutations in polymerase gamma. Arch Neurol (2003) 1.29
Lack of paternal inheritance of muscle mitochondrial DNA in sporadic mitochondrial myopathies. Ann Neurol (2003) 1.28
Mitochondrial diseases: therapeutic approaches. Biosci Rep (2007) 1.28
Mitochondria and neurodegeneration. Biosci Rep (2007) 1.22
Multicenter case-control study on restless legs syndrome in multiple sclerosis: the REMS study. Sleep (2008) 1.22
Mitochondrial dysfunction, oxidative stress and neurodegeneration. J Alzheimers Dis (2006) 1.20
POLG mutations and Alpers syndrome. Ann Neurol (2005) 1.19
The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: a meta-analysis study. J Alzheimers Dis (2010) 1.19
Mitochondrial DNA depletion and dGK gene mutations. Ann Neurol (2002) 1.17
Intravenous thrombolysis with rt-PA in acute ischemic stroke patients aged older than 80 years in Italy. Cerebrovasc Dis (2007) 1.12
Association of thymoma and myasthenia gravis: oncological and neurological results of the surgical treatment. Eur J Cardiothorac Surg (2009) 1.12
Daytime sleepiness in mild and moderate Alzheimer's disease and its relationship with cognitive impairment. J Sleep Res (2005) 1.11
Genes and the environment in neurodegeneration. Biosci Rep (2006) 1.11
Proton MR spectroscopy of mitochondrial diseases: analysis of brain metabolic abnormalities and their possible diagnostic relevance. AJNR Am J Neuroradiol (2003) 1.05
Novel mitochondrial tRNA Leu(CUN) transition and D4Z4 partial deletion in a patient with a facioscapulohumeral phenotype. Neuromuscul Disord (2008) 1.05
POLG1-related and other "mitochondrial Parkinsonisms": an overview. J Mol Neurosci (2011) 1.05
Could mitochondrial haplogroups play a role in sporadic amyotrophic lateral sclerosis? Neurosci Lett (2004) 1.04
Progressive external ophthalmoplegia and vision and hearing loss in a patient with mutations in POLG2 and OPA1. Arch Neurol (2008) 1.04
Changes in pattern electroretinograms to equiluminant red-green and blue-yellow gratings in patients with early Parkinson's disease. J Clin Neurophysiol (2003) 1.03
Novel mitochondrial DNA ND5 mutation in a patient with clinical features of MELAS and MERRF. Arch Neurol (2005) 1.03
Sleep quality, chronotypes and preferential timing of attacks in migraine without aura. J Headache Pain (2005) 1.02
The chemical neuroanatomy of vagus nerve stimulation. J Chem Neuroanat (2010) 1.01
Coenzyme Q10 is frequently reduced in muscle of patients with mitochondrial myopathy. Neuromuscul Disord (2009) 1.01
Silent cerebral ischemia detected with diffusion-weighted imaging in patients treated with protected and unprotected carotid artery stenting. Stroke (2005) 1.00
Evidence of the association of BIN1 and PICALM with the AD risk in contrasting European populations. Neurobiol Aging (2011) 1.00
Dopaminergic modulation of visual-spatial working memory in Parkinson's disease. Dement Geriatr Cogn Disord (2003) 1.00
MMP9 variation after thrombolysis is associated with hemorrhagic transformation of lesion and death. Stroke (2013) 0.98
Functional magnetic resonance imaging in episodic cluster headache. J Headache Pain (2008) 0.97
Systemic thrombolysis in patients with acute ischemic stroke and Internal Carotid ARtery Occlusion: the ICARO study. Stroke (2011) 0.96
The role of norepinephrine in epilepsy: from the bench to the bedside. Neurosci Biobehav Rev (2004) 0.96
Oxidative stress biomarkers in mitochondrial myopathies, basally and after cysteine donor supplementation. J Neurol (2009) 0.96
The role of mitochondria in stem cell biology. Biosci Rep (2007) 0.95
Decreased platelet cytochrome c oxidase activity is accompanied by increased blood lactate concentration during exercise in patients with Alzheimer disease. Exp Neurol (2003) 0.94
Analysis of RR variability in drug-resistant epilepsy patients chronically treated with vagus nerve stimulation. Auton Neurosci (2003) 0.93
The THRombolysis and STatins (THRaST) study. Neurology (2013) 0.92
Human mitochondrial transcription factor A reduction and mitochondrial dysfunction in Hashimoto's hypothyroid myopathy. Mol Med (2002) 0.92
Absence of angiogenic genes modification in Italian ALS patients. Neurobiol Aging (2006) 0.92
A damage to locus coeruleus neurons converts sporadic seizures into self-sustaining limbic status epilepticus. Eur J Neurosci (2003) 0.92
Epilepsy after neuroimaging normalization in a woman with tacrolimus-related posterior reversible encephalopathy syndrome. Epilepsy Behav (2010) 0.90
Cerebral perfusional effects of cholinesterase inhibitors in Alzheimer disease. Clin Neuropharmacol (2004) 0.90
Genetic or pharmacological blockade of noradrenaline synthesis enhances the neurochemical, behavioral, and neurotoxic effects of methamphetamine. J Neurochem (2007) 0.90
Predictive value of nigrostriatal dysfunction in isolated tremor: a clinical and SPECT study. Mov Disord (2008) 0.90
Current options in the treatment of mitochondrial diseases. Recent Pat CNS Drug Discov (2010) 0.88
Citalopram as treatment of depression in patients with epilepsy. Clin Neuropharmacol (2004) 0.88
Can microembolic signals identify unstable plaques affecting symptomatology in carotid stenosis? Stroke (2002) 0.88
Insulinoma presenting as idiopathic hypersomnia. Neurol Sci (2010) 0.88
Mitochondrial encephalomyopathies: therapeutic approach. Ann N Y Acad Sci (2004) 0.88
Mitochondrial cascade hypothesis of Alzheimer's disease: myth or reality? Antioxid Redox Signal (2007) 0.86
Daytime sleepiness in epilepsy patients receiving topiramate monotherapy. Epilepsia (2004) 0.86
In stent restenosis predictors after carotid artery stenting. Stroke Res Treat (2010) 0.86
Daytime vigilance and quality of life in epileptic patients treated with vagus nerve stimulation. Epilepsy Behav (2003) 0.86
Prevalence of stroke and transient ischaemic attack in the elderly population of an Italian rural community. Eur J Epidemiol (2003) 0.86
D90A-SOD1 mutation in ALS: The first report of heterozygous Italian patients and unusual findings. Amyotroph Lateral Scler (2010) 0.86
The first Italian family with evidence of pyramidal impairment as phenotypic manifestation of Silver syndrome BSCL2 gene mutation. Neurol Sci (2008) 0.85
Mitochondrial non-syndromic sensorineural hearing loss: a clinical, audiological and pathological study from Italy, and revision of the literature. Biosci Rep (2008) 0.85
A case of recurrent basilar artery occlusion successfully treated with repeated intravascular procedures. Neurologist (2011) 0.84
Sleep-related migraine occurrence increases with aging. Acta Neurol Belg (2012) 0.84
Oxidative stress biomarkers in patients with untreated obstructive sleep apnea syndrome. Sleep Med (2012) 0.84
Progressive external ophthalmoplegia: a new family with tremor and peripheral neuropathy. Am J Med Genet A (2005) 0.84
Human dental pulp stem cells protect mouse dopaminergic neurons against MPP+ or rotenone. Brain Res (2010) 0.84
Impaired oxidative metabolism and lipid peroxidation in exercising muscle from ALS patients. Amyotroph Lateral Scler Other Motor Neuron Disord (2002) 0.84
Mitochondrial dysfunction and Alzheimer's disease: new developments. J Alzheimers Dis (2006) 0.84
May "mitochondrial eve" and mitochondrial haplogroups play a role in neurodegeneration and Alzheimer's disease? Int J Alzheimers Dis (2011) 0.83
Association of the hOGG1 Ser326Cys polymorphism with sporadic amyotrophic lateral sclerosis. Neurosci Lett (2007) 0.83
Prevalence of right-to-left shunt in patients with cluster headache. J Headache Pain (2005) 0.83
A Ser326Cys polymorphism in the DNA repair gene hOGG1 is not associated with sporadic Alzheimer's disease. Neurosci Lett (2006) 0.83
Parkinson's disease and pathological gambling: results from a functional MRI study. Mov Disord (2010) 0.83
Locus coeruleus and neuronal plasticity in a model of focal limbic epilepsy. Epilepsia (2006) 0.83
DNA fragmentation and oxidative stress in the hippocampal formation: a bridge between 3,4-methylenedioxymethamphetamine (ecstasy) intake and long-lasting behavioral alterations. Behav Pharmacol (2007) 0.83
Postpartum headache due to spontaneous cervical artery dissection. Headache (2011) 0.82
Lithium in ALS: from the bench to the bedside. Amyotroph Lateral Scler (2008) 0.82
DNMT3B promoter polymorphisms and risk of late onset Alzheimer's disease. Curr Alzheimer Res (2012) 0.82
Influences of dopaminergic treatment on motor cortex in Parkinson disease: a MRI/MRS study. Mov Disord (2007) 0.82
Association study between XRCC1 gene polymorphisms and sporadic amyotrophic lateral sclerosis. Amyotroph Lateral Scler (2010) 0.82
Mitochondrial encephalomyopathies: diagnostic approach. Ann N Y Acad Sci (2004) 0.82
Lactate production and catecholamine profile during aerobic exercise in normotensive OSAS patients. Sleep Med (2004) 0.82
Functional diagnostics in mitochondrial diseases. Biosci Rep (2007) 0.82